Pluri Inc. (PluriStem Life Systems, Inc.) 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on November 21, 2005, by PluriStem Life Systems, Inc., a Nevada corporation headquartered in Haifa, Israel. The report discloses material corporate governance changes and the entry into a significant consulting agreement effective December 1, 2005.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or liquidity metrics. The only specific financial data disclosed relates to the new consulting agreement:
- Consulting Retainer: 60,000 New Israeli Shekels per month (approximately $12,755.50 USD at the time of filing), plus Value Added Tax.
- Equity Compensation: Grant of options to purchase 1,500,000 common shares at the market price on the date of grant, vesting over two years.
- Other Benefits: Provision of a cellular phone and company car to the consultant.
Material Changes
The filing reports two primary material changes:
- Entry into Material Definitive Agreement: Execution of a consulting agreement with Meretzki Consulting Ltd. (wholly owned by Dr. Shai Meretzki) for a term running from December 1, 2005, to May 1, 2008.
- Appointment of Director: On November 21, 2005, Mr. Zami Aberman, the company's President and CEO, was appointed to the Board of Directors.
Outlook, Risks, and Management Commentary
The filing contains no forward-looking guidance, risk factors, or management commentary regarding future financial performance or strategic outlook beyond the execution of the specific agreements noted above. No unusual items or contingencies were disclosed in this report.
Key Facts for Investor Verification
- Verify the total annual cost of the new consulting agreement, including the monthly retainer, VAT, and the estimated fair value of the 1.5 million share options.
- Confirm the impact of the new director appointment on the composition and independence of the Board of Directors.
- Review the vesting schedule and exercise terms of the options granted to Dr. Shai Meretzki to assess potential dilution.
- Check subsequent filings for any financial impact of this agreement on the company's operating expenses.